Elizabeth Hanna
Direktor/Vorstandsmitglied bei TREACE MEDICAL CONCEPTS, INC.
Vermögen: 219 658 $ am 30.04.2024
Profil
Elizabeth S.
Hanna is an Independent Director at Treace Medical Concepts, Inc. She previously held positions as Vice President-Global Strategic Marketing at Johnson & Johnson from 2012 to 2014, President & Chief Operating Officer at Origin Life Sciences, Inc. from 2014 to 2018, and Member-Global Management Board at Johnson & Johnson Vision Care, Inc. from 2012 to 2014.
She also served as Chief Commercial Officer at Clinical Genomics Technologies Pty Ltd.
from 2018 to 2019.
Ms. Hanna will be joining Agendia, Inc. as Chief Commercial Officer & Executive VP in 2022.
She completed her undergraduate degree at the University of Illinois and holds an MBA from Harvard Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 21.05.2024 | 21 326 ( 0,03% ) | 219 658 $ | 30.04.2024 |
Aktive Positionen von Elizabeth Hanna
| Unternehmen | Position | Beginn |
|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. | Direktor/Vorstandsmitglied | 01.10.2021 |
Ehemalige bekannte Positionen von Elizabeth Hanna
| Unternehmen | Position | Ende |
|---|---|---|
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Corporate Officer/Principal | 01.09.2023 |
Origin Life Sciences, Inc.
 Origin Life Sciences, Inc. BiotechnologyHealth Technology Origin Life Sciences, Inc. is a clinical-stage biotechnology company, which engages in the development of a plasma device that generate nitric oxide (NO) in the form of a plasma or NO stream. It focuses on its IonoJet platform, which provides therapeutic treatments which helps in immune system and blood vessel regulation, and tissue regeneration. The company was founded by Michael D. Preston and Alexander Dolgopolsky on June 14, 2010 and is headquartered in Princeton, NJ. | Präsident | 01.01.2018 |
| JOHNSON & JOHNSON | Vertrieb & Marketing | 01.04.2014 |
Johnson & Johnson Vision Care, Inc.
 Johnson & Johnson Vision Care, Inc. Electronic ComponentsElectronic Technology Johnson & Johnson Vision Care, Inc. manufactures and markets vision care products. The company was founded on March 07, 1962 and is headquartered in Jacksonville, FL. | Corporate Officer/Principal | 01.04.2014 |
Clinical Genomics Technologies Pty Ltd.
 Clinical Genomics Technologies Pty Ltd. Medical/Nursing ServicesHealth Services Clinical Genomics Technologies Pty Ltd. manufactures and sells healthcare solutions for the early detection and prevention of disease. The company was founded by Lawrence LaPointe, Richard J. Sands and Susanne K. Pedersen in September 2006 and is headquartered in North Ryde, Australia. | Vorstandsvorsitzender | - |
Ausbildung von Elizabeth Hanna
| University of Illinois | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| TREACE MEDICAL CONCEPTS, INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Clinical Genomics Technologies Pty Ltd.
Clinical Genomics Technologies Pty Ltd. Medical/Nursing ServicesHealth Services Clinical Genomics Technologies Pty Ltd. manufactures and sells healthcare solutions for the early detection and prevention of disease. The company was founded by Lawrence LaPointe, Richard J. Sands and Susanne K. Pedersen in September 2006 and is headquartered in North Ryde, Australia. | Health Services |
Origin Life Sciences, Inc.
Origin Life Sciences, Inc. BiotechnologyHealth Technology Origin Life Sciences, Inc. is a clinical-stage biotechnology company, which engages in the development of a plasma device that generate nitric oxide (NO) in the form of a plasma or NO stream. It focuses on its IonoJet platform, which provides therapeutic treatments which helps in immune system and blood vessel regulation, and tissue regeneration. The company was founded by Michael D. Preston and Alexander Dolgopolsky on June 14, 2010 and is headquartered in Princeton, NJ. | Health Technology |
Johnson & Johnson Vision Care, Inc.
Johnson & Johnson Vision Care, Inc. Electronic ComponentsElectronic Technology Johnson & Johnson Vision Care, Inc. manufactures and markets vision care products. The company was founded on March 07, 1962 and is headquartered in Jacksonville, FL. | Electronic Technology |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Health Technology |
